SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-120839
Filing Date
2019-04-26
Accepted
2019-04-26 07:12:03
Documents
7
Period of Report
2019-06-06
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d685790ddef14a.htm DEF 14A 363787
2 GRAPHIC g685790g01i62.jpg GRAPHIC 22140
3 GRAPHIC g685790g11y77.jpg GRAPHIC 26592
4 GRAPHIC g685790g21j11.jpg GRAPHIC 24658
5 GRAPHIC g685790g28x89.jpg GRAPHIC 31678
6 GRAPHIC g685790g56z83.jpg GRAPHIC 16586
7 GRAPHIC g685790g57f70.jpg GRAPHIC 22487
  Complete submission text file 0001193125-19-120839.txt   564189
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38584 | Film No.: 19769338
SIC: 2834 Pharmaceutical Preparations